261 – 270 of 533
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
30 procents risk få prostatacancer om en bror har diagnosen
(
- Contribution to journal › Article
-
Mark
Preclinical Characterization of 3β-(N-Acetyl l -cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Validation of novel biomarkers for prostate cancer progression by the combination of bioinformatics, clinical and functional studies
(
- Contribution to journal › Article
-
Mark
Catheter-associated urinary tract infections and other infections in patients hospitalized for acute stroke : A prospective cohort study of two different silicone catheters
(
- Contribution to journal › Article
-
Mark
Reduction of quality of life in prostate cancer patients : experience among 6200 men in the Nordic countries
(
- Contribution to journal › Article
-
Mark
PBX3 is a putative biomarker of aggressive prostate cancer
(
- Contribution to journal › Article
-
Mark
Re: Risk of malignant melanoma in men with prostate cancer. Nationwide, population-based cohort study
(
- Contribution to journal › Letter
-
Mark
Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort
(
- Contribution to journal › Article
-
Mark
Making Predictive Biomarkers Readily Available
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Value of treatment in clinical trials versus the real world : the case of abiraterone acetate (Zytiga) for postchemotherapy metastatic castration-resistant prostate cancer patients in Sweden
(
- Contribution to journal › Article